SCHEMBL9702924

SCHEMBL9702924

COc1cc([S+](C)[O-])ccc1-c1nc2cc3[nH]c(=O)cnc3cc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 11/20 0.41
PDE5A O76074 4/20 0.41
PDE3B Q13370 2/20 0.41
PDE3A Q14432 2/20 0.41
PDE2A O00408 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
MAPKAPK2 P49137 1/20 0.34
RPS6KA3 P51812 1/20 0.34
CSNK2A1 P68400 1/20 0.34
PLK3 Q9H4B4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703649 0.86 AMY1A (0.43) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL10852513 0.83 AMY1A (0.40) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL9702805 0.82 CDK4 (0.45) AMY1APDE5APDE3BPDE3A
SCHEMBL9705442 0.80 KDM4E (0.41) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL10742305 0.80 PDE5A (0.47) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL9704436 0.80 PDE5A (0.43) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL10551908 0.78 AMY1A (0.39) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL10373752 0.78 PDE3B (0.48) AMY1APDE5APDE3BPDE3APDE2A
Isomazole SCHEMBL30578156 0.78 PDE5A (0.51) AMY1APDE5APDE3BPDE3APDE2A
SCHEMBL10688962 0.78 PDE2A (0.37) AMY1APDE5APDE3BPDE3APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed